Serina Therapeutics SER
NYSE SER
$2.72 +0.07 (+2.40%)
As of: Aug 21, 2026 · 12:48 PM EDT

Serina Therapeutics (SER) Construction in Progress (2019)

Serina Therapeutics (SER) posted Construction in Progress of $329000.0 for Q3 2019, up 93.53% sequentially from $170000.0 in Q2 2019.

Serina Therapeutics (SER) Construction in Progress (2019) Analysis & Trends

Serina Therapeutics has reported Construction in Progress for 1 years, with the latest figure at $329000.0 in Q3 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Vertex Pharmaceuticals 139.57 Bn 131.72 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 86.71 Bn 78.72 Bn 3.93 Bn -
3 Argenx Se 65.44 Bn 60.25 Bn 1.37 Bn -
4 Moderna 60.06 Bn 54.93 Bn 52.00 Mn -
5 BeOne Medicines 42.16 Bn 37.06 Bn 1.53 Bn 152.67 Mn
6 Alnylam Pharmaceuticals 31.89 Bn 28.58 Bn 992.69 Mn -
7 BioNTech SE 28.11 Bn 9.72 Bn 668.28 Mn -
8 Insmed 27.59 Bn 26.43 Bn 358.27 Mn -
9 Royalty Pharma 27.33 Bn 26.49 Bn - -
10 Serina Therapeutics 44.50 Mn 21.48 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2019 329,000.00
Jun 30, 2019 170,000.00